EPATITE CRONICA DA VIRUS B. DUSHEIKO E COLL. SUI NUOVI APPROCCI ! DA “NEJM” (FREE).
New Approaches to Chronic Hepatitis B Geoffrey Dusheiko et al. Chronic hepatitis B is caused by the hepatitis B virus…
Approfondisci...
LA REVIEW DI”LANCET” SUI VACCINO ANTICANCRO A BASE DI mRNA. GRANDE. DA LEGGERE SUBITO! (FREE)
EPATOLOGIA, EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, INTERNATIONAL SNAPSHOTS, MEDICINA INTERNA, ONCOLOGIA, Senza categoriaDi Redazione
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment Cathrine Lund Lorentzen et al. Summary Years of research…
ACCURATEZZA DIAGNOSTICA DELLA ENDOMICROSCOPIA LASER PER LE STENOSI COLANGIOPANCREATICHE IN CPRE: UNA META-ANALISI (FREE)
ECOGRAFIA ED ECOENDOSCOPIA, ENDOSCOPIA, EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, PANCREAS E VIE BILIARI, Senza categoriaDi Redazione
Diagnostic accuracy of probe‑based confocal laser endomicroscopy and tissue sampling by endoscopic retrograde cholangiopancreatography in indeterminate biliary strictures: a meta‑analysis…
EPATOCARCINOMA DA EPATITE CRONICA DA VIRUS B. ENTECAVIR vs TENOFOVIR. UNA COORTE NAZIONALE DALLA COREA. “JAMA ONCOLOGY” (FREE)
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study…
MARCATORI PER IL CARCINOMA EPATOCELLULARE: IL “WHITE PAPER” DALLA INTERNATIONAL LIVER CANCER ASSOCIATION
CHIRURGIA, EPATOLOGIA, EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, LINEE GUIDA EBM, MEDICI DI FAMIGLIA, MEDICINA INTERNA, Senza categoriaDi Redazione
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma Amit G. Singal et al. Biomarkers are…
REGORAFENIB DOPO TACE PER CARCINOMA EPATICO NON RESECABILE: UNO STUDIO DI REAL-WORLD EVIDENCE
Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study Yue Han et al. Abstract Background The benefits…
REGORAFENIB E CHEMOEMBOLIZZAZIONE PER L’EPATOCARCINOMA NON RESECABILE. UNO STUDIO POSITIVO DI REAL WORLD EVIDENCE
Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study Yue Han et al. Abstract Background The benefits…
PREVENZIONE DELL’HCC CON FANS ED ANTI-AGGREGANTI: UNA GRANDE META-ANALISI DA APT
Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular…
IL BENEFICIO IN TERMINI DI SOPRAVVIVENZA E’ RIDOTTO AD ASSENTE PER I FARMACI ONCOLOGICI APPROVATI : L’ESPERIENZA CANADESE
Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada Daniel E. Meyers et al.…
TENOFOVIR MEGLIO DI ENTECAVIR PER PREVENIRE HCC IN EPATITE CRONICA DA VIRUS B? UN’OTTIMA META-ANALISI
Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and…
TERLIPRESSINA FA REGREDIRE LA SINDROME EPATORENALE DI TIPO 1 NEL 40% DEI CASI
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome Florence Wong, et al. Abstract BACKGROUND The vasoconstrictor terlipressin…
Imaging +alfafeto per la diagnosi precoce di HCC
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.Tzartzeva K, Obi J,…
Terapie per pazienti affetti da HCC in attesa di trapianto
Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.Kulik L, Heimbach JK, Zaiem F,…
Trattamento con RF dell’HCC come bridge therapy al trapianto
Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.Lee MW, Raman SS, Asvadi…
Nuovi criteri estesi per il trapianto epatico nei pazienti con HCC
The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer .Michał Grąt, Karolina M.…
“Imaging Schedule” dopo trapianto epatico per HCC
Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.Liu D1, Chan AC, Fong DY, Lo CM, Khong PL.…
Entecavir riduce rischio HCC in HBV+
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.Ahn J, Lim…
Risposta alla TACE come criterio di selezione per l’epatectomia
Response to transarterial chemoembolization as a selection criterion for resection of hepatocellular carcinomas.Lei JY, Zhong JJ, Yan LN, Zhu JQ,…
Rischio di HCC in pz HCV+con SVR
Risk Factors of HCC Development in Non-cirrhotic Patients with Sustained Virologic Response for Chronic HCV Infection.Toyoda H1, Kumada T, Tada…
Ipertensione portale influenza outcome del trattamento chirurgico dell’HCC
Portal hypertension on the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.Berzigotti A, Reig…
ADRESS-HCC risk model
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model. Flemming JA, Yang JD, Vittinghoff E, Kim…
Review sistematica sullo screening dell’HCC
Screening for Hepatocellular Carcinoma in Chronic Liver Disease: A Systematic Review.Kansagara D, Papak J, Pasha AS, O’Neil M, Freeman M,…
Fattori che condizionano accuratezza dell’ alfa-fetoproteina nella diagnosi di HCC
Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.Gopal P, Yopp AC, Waljee…
Impatto economico dell’algoritmo AASLD per la diagnosidi HCC
Clinical and Economical Impact of 2010 AASLD Guidelines for the Diagnosis of Hepatocellular Carcinoma.Manini MA, Sangiovanni A, Fornari F, Piscaglia…
